---
schema_version: "secwatch.filing_event.v1"
accession: "0001764046-26-000090"
form_type: "8-K"
ticker: "CLVT"
cik: "0001764046"
company_name: "CLARIVATE PLC"
filed_at: "2026-07-29T10:03:16+00:00"
generated_at: "2026-07-29T10:10:30.462294+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clarivate Q2 revenue down 5.5% to $587M; net loss $269M on goodwill impairment; reaffirms FY outlook

## Summary
- Q2 total revenues $587.3M, down 5.5% YoY; organic revenue -1.5% as subscription +0.7% offset by transactional -15.7%.
- Net loss $268.6M ($0.42 diluted EPS) vs $72.0M loss in Q2 2025, driven by $221.7M non-cash goodwill impairment.
- Adjusted net income $123.1M ($0.19 diluted EPS) vs $123.3M ($0.18) in Q2 2025; adjusted EBITDA $247.2M vs $261.6M.
- First-half 2026 free cash flow $122.9M vs $160.6M prior year; debt reduced by $218.4M including $100M accelerated repayment.
- Reaffirms full-year 2026 outlook; previously announced Life Sciences & Healthcare segment divestiture ongoing.

## SEC filing metadata
- accession: 0001764046-26-000090
- form_type: 8-K
- ticker: CLVT
- cik: 0001764046
- company_name: CLARIVATE PLC
- filed_at: 2026-07-29T10:03:16+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764046/000176404626000090/0001764046-26-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764046/000176404626000090/clvt-20260729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764046-26-000090
- JSON: https://secwatch.observer/filing/0001764046-26-000090.json
- Plain text: https://secwatch.observer/filing/0001764046-26-000090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.